Clinical Trial Update: Nelfinavir in Recurrent Adenoid Cystic Cancer of the Head and Neck [Phase 2]

View source ↗

Summary

Phase 2 trial investigating nelfinavir in recurrent adenoid cystic carcinoma of the head and neck has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenoid Cystic Carcinoma of Head and Neck
• Head and Neck Neoplasms

Drugs mentioned

• Nelfinavir (nelfinavir)

Snippet

Sponsor: University of Iowa | Conditions: Carcinoma, Adenoid Cystic, Head and Neck Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2016-12-19